NSC |
Compound |
Enrichment |
Correlation |
NSC 733397 |
1-alpha-methyl-8-methoxy-5-bromo-6,7,-methylenedioxy-1-(6,7, -dimethoxy-3-phthalidyl)-1,2,3,4-tetrahydroisoquinoline |
0.0295480456086945 |
0.080180472 |
NSC 734296 |
6-(3-Bromopropyl)-5,6-dihydro-8,9-dimethoxy-3-nitro-5,11-dio xo-11H-indeno[1,2-c]isoquinoline |
0.0295480456086945 |
0.13720999 |
NSC 736793 |
Null |
0.0295480456086945 |
0.23913851 |
NSC 746684 |
7-{[3-(dibutylamino)propyl]amino}-5-imino-1,3,6-triphenyl-5,6-dihydropyrimido[4,5-d]pyrimidine-2,4(1H,3H)-dithione |
0.0295480456086945 |
0.14059301 |
NSC 749160 |
Null |
0.0295480456086945 |
0.40829568 |
NSC 105132 |
Deoxycamptothecin |
0.0295480456086947 |
0.030217903 |
NSC 132791 |
Butyric acid, 2-hydroxy-2-methyl-, 4-ester with 1,3a.beta.,4,7,7a.alpha.,11,11a,11b.alpha.-octahydro-1.alpha.,2.alpha.,4.beta.,11.beta.-tetrahydroxy-3.alpha.,8,11a.beta.-trimethyl-2H-1,11c.beta.-(epo |
0.0295480456086947 |
0.27916333 |
NSC 134723 |
K 31 |
0.0295480456086947 |
0.076842229 |
NSC 149765 |
1,4-Pentanediamine, N4-(6-methoxy-8-quinolinyl)-, phosphate (1:2) (9CI) |
0.0295480456086947 |
0.066950403 |
NSC 175493 |
Iron, carbonyl(.eta.(5)-2,4-cyclopentadien-1-yl)(dimethylcarbamodithioato-S,S')- |
0.0295480456086947 |
0.20511079 |